QUICKLINKS AND VIEW OPITONS
Proton pump inhibitors (PPI’s) increase risk of Alzheimer’s by 44%
Tuesday, May 22, 2018 7:37 am Email this article
Patients 75 years and older taking a proton pump inhibitor (PPI) were 38% more likely to have any type of dementia and 44% more likely to have Alzheimer’s than non-users according to a study from Germany.
List of PPI’s
Available proton pump inhibitors include:
- omeprazole (Prilosec, Prilosec OTC)
- aspirin and omeprazole (Yosprala)
- lansoprazole (Prevacid, Prevacid IV, Prevacid 24-Hour)
- dexlansoprazole (Dexilent, Dexilent Solutab)
- rabeprazole (Aciphex, Aciphex Sprinkle)
- pantoprazole (Protonix)
- esomeprazole (Nexium, Nexium IV, Nexium 24 HR)
- esomeprazole magnesium/naproxen (Vimovo)
- omeprazole/sodium bicarbonate (Zegerid, Zegerid OTC)
Haenisch B, von Holt K, Wiese B, Prokein J, Lange C, Ernst A, Brettschneider C, Konig HH, Werle J, Weyerer S, Luppa M, Riedel-Heller SG, Fuchs A, Pentzek M, Weeg D, Bickel H, Broich K, Jessen F, Maier W, and Scherer M. Risk of dementia in elderly patients with the use of proton pump inhibitors. Eur Arch Psychiatry Clin Neurosci, 2015 Aug; 265(5): 419-428.
Author’s Contact Info
German Center for Neurodegenerative Diseases (DZNE)
c/o Federal Institute for Drugs and Medical Devices (BfArM)
53175, Bonn, Germany
Articles on the same subject can be found here:
Please feel free to share your comments about this article.
© Copyright 2003-2021 - Larry Hobbs - All Rights Reserved.